Largest Phase 3 Trial of Psilocybin for Depression Has Begun | Psychedelic spotlight
As our social fabric is unraveling and rates of depression continue to rise, affecting an estimated 310 million people worldwide, psilocybin research has given us a glimmer of hope that…